Citizens Reiterates Market Outperform on BeOne Medicines, Maintains $396 Price Target
Citizens analyst Reni J. Benjamin reiterates BeOne Medicines (NASDAQ: ONC ) with a Market Outperform and maintains $396 price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.